19-47780729-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003009.4(SELENOW):c.34G>A(p.Ala12Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000111 in 1,561,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000060 ( 0 hom., cov: 28)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
SELENOW
NM_003009.4 missense
NM_003009.4 missense
Scores
1
1
8
Clinical Significance
Conservation
PhyloP100: 1.79
Genes affected
SELENOW (HGNC:10752): (selenoprotein W) This gene encodes a selenoprotein containing a selenocysteine (Sec) residue, which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element that is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. This protein is highly expressed in skeletal muscle, heart and brain. It belongs to the SelWTH family, which possesses a thioredoxin-like fold and a conserved CxxU (C is cysteine, U is Sec) motif, suggesting a redox function for this gene. Studies in mouse show that this selenoprotein is involved in muscle growth and differentiation, and in the protection of neurons from oxidative stress during neuronal development. A retroprocessed pseudogene of this locus has been identified on chromosome 1. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1724878).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SELENOW | NM_003009.4 | c.34G>A | p.Ala12Thr | missense_variant | 2/6 | ENST00000601048.6 | NP_003000.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SELENOW | ENST00000601048.6 | c.34G>A | p.Ala12Thr | missense_variant | 2/6 | 1 | NM_003009.4 | ENSP00000473185.1 |
Frequencies
GnomAD3 genomes AF: 0.0000596 AC: 9AN: 151092Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
9
AN:
151092
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000743 AC: 13AN: 174850Hom.: 0 AF XY: 0.0000862 AC XY: 8AN XY: 92822
GnomAD3 exomes
AF:
AC:
13
AN:
174850
Hom.:
AF XY:
AC XY:
8
AN XY:
92822
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000116 AC: 164AN: 1410538Hom.: 0 Cov.: 30 AF XY: 0.000115 AC XY: 80AN XY: 696806
GnomAD4 exome
AF:
AC:
164
AN:
1410538
Hom.:
Cov.:
30
AF XY:
AC XY:
80
AN XY:
696806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000596 AC: 9AN: 151092Hom.: 0 Cov.: 28 AF XY: 0.0000407 AC XY: 3AN XY: 73650
GnomAD4 genome
AF:
AC:
9
AN:
151092
Hom.:
Cov.:
28
AF XY:
AC XY:
3
AN XY:
73650
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
13
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.34G>A (p.A12T) alteration is located in exon 2 (coding exon 2) of the SEPW1 gene. This alteration results from a G to A substitution at nucleotide position 34, causing the alanine (A) at amino acid position 12 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;.;T
MetaRNN
Benign
T;T;T;T
PrimateAI
Pathogenic
D
Sift4G
Benign
T;T;T;T
Polyphen
D;.;D;D
Vest4
MVP
MPC
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at